Bruker price target lowered to $43 from $46 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker (BRKR) to $43 from $46 and keeps an Overweight rating on the shares. The firm said it knew Q2 orders were going to be soft, and the biggest question on the day was what guidance implied for the second half. With a steep second half ramp, and most coming in Q4, investors have little appetite for this type of outlook in the uncertain macro, and as such, Bruker sentiment is likely to remain bearish, the analyst tells investors in a research note.